Key Commentary Archives - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Key Commentary

Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization

The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Fluid management in sepsis

20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)

Long intravascular persistence of 20% albumin in postoperative patients

Association between albumin administration and survival in cardiac surgery: a retrospective cohort study

Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

Small volume resuscitation with 20% albumin in intensive care: physiological effects: The SWIPE randomised clinical trial

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites

Comment: Long-term albumin in cirrhosis: is it the ANSWER?

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial